AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg) + Voglibose (0.2mg)

Overview Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR

Diabetic patients, specifically adults with type 2 diabetes mellitus, may benefit from Glyconia Forte, a triple-combination anti-diabetic medication. This formulation effectively manages blood glucose levels. Glyconia Forte should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual blood glucose monitoring. Consistent use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications including nephropathy, retinopathy, neuropathy, and limb loss. Remember, Glyconia Forte complements a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as recommended by your healthcare provider. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Maintain regular meals, carry readily available glucose sources (e.g., sugary snacks or juice), and avoid alcohol to mitigate this risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Glyconia Forte is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Pre-existing heart conditions should be disclosed to your doctor before commencing treatment. Expectant and breastfeeding mothers must consult their physician before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Voglow GM 1 Forte 1mg/1000mg/0.2mg Extended-Release Tablet on an empty stomach.

Common Side effects of Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Voglow GM 1 Forte 1mg/1000mg/0.2mg Sustained-Release tablets on an empty stomach.

How Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR works:

Voglow GM 1 Forte, a sustained-release tablet (1mg/1000mg/0.2mg), combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Voglow GM 1 Forte 1mg/1000mg/0.2mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglow GM 1 Forte 1mg/1000mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Voglow GM 1 Forte 1mg/1000mg/0.2mg SR tablets is likely inadvisable. Available evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The extended-release Voglow GM 1 Forte 1mg/1000mg/0.2mg tablet is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Its use is contraindicated in patients experiencing severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver disease should use Voglow GM 1 Forte 1mg/1000mg/0.2mg SR tablets cautiously, potentially requiring dose modification. Consult a physician. A low starting dose is generally recommended for those with mild to moderate liver impairment; the medication is unsuitable for patients with severe liver disease.

What if you forget to take Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR :

Should you forget a dose of Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR

Voglow GM 1 Forte, a combined Glimepiride (1mg), Metformin (1000mg), and Voglibose (0.2mg) sustained-release tablet, treats type 2 diabetes mellitus in adults. It improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; Metformin reduces liver glucose production and enhances insulin sensitivity; and Voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 diabetes.
Voglow GM 1 Forte 1mg/1000mg/0.2mg SR Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infection.
Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Voglow GM 1 Forte 1mg/1000mg/0.2mg Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglow GM 1 Forte can cause low blood sugar (hypoglycemia), with symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness. This risk increases if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly sealed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglow GM 1 Forte 1mg/100...
106
MRP 129
17% off